Profile picture of Bloomberg
Paul Singer's Elliott Buys a Stake in BioMarin. Can a Deal Be Far Behind?: The feared activist has popped up at rare diseases specialist BioMarin.
bloomberg.com/opinion/articles/2023-11-10/paul-singer-s-elliott-buys-a-stake-in-biomarin-can-a-deal-be-far-behind
Paul Singer's Elliott Buys a Stake in BioMarin. Can a Deal Be Far ...
Profile picture of Bloomberg
UK Drugmaker GSK Needs to Show It’s Kicked the Dealmaking Addiction: The UK drugmaker has undergone huge structural change. But its core challenge remains: ...
bloomberg.com/opinion/articles/2023-07-25/uk-drugmaker-gsk-needs-to-show-it-s-kicked-the-dealmaking-addiction
UK Drugmaker GSK Needs to Show It’s Kicked the Dealmaking Addiction
Profile picture of The Times
Rishi Sunak urged to let drug firms use NHS data for new medicines: Rishi Sunak has been urged by Britain’s biggest drug maker to do more to allow NHS data to be ...
thetimes.co.uk/article/rishi-sunak-nhs-data-drugs-medicine-2023-rdg7ln3p5
Rishi Sunak urged to let drug firms use NHS data for new medicines
Profile picture of The Guardian
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge: Emma Walmsley says ambition to be pharma superpower at risk unless improvements ...
theguardian.com/business/2023/feb/01/gsk-boss-warns-uk-life-sciences-at-tipping-point-despite-sunak-spending-pledge
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D ...
Profile picture of Fortune (magazine)
The 50 Most Powerful Women: #1 Karen Lynch · #2 Julie Sweet · #3 Jane Fraser · #4 Mary Barra · #5 Jessica Tan · #6 Carol Tomé · #7 Rosalind Brewer · #8 Emma ...
fortune.com/most-powerful-women/2022/
The 50 Most Powerful Women